I'm sorry you're having an issue with your pancreas. Please take a lot of time off and stop posting.
Really? Patients have died taking rituximab, ipilimumab, bevacizumab, etc. etc. etc. Are Roche and BMS toast? I wasn't aware.
You can feed a mouse a little piece of chewing gum and its tumors will collapse. I'm hoping there's more to Roche's enthusiasm than preclinical data.
If you're suggesting not keeping the stock more than one day, then you must be a day trader too. But you're a sad one, because you aren't making any money.
Dorris doesn't have a special gift. This stock has been floundering for months, a fact that several posters have pointed out in much more rational ways than dorris.
You're a dog. The pps did move yesterday. Were you thinking it should have doubled on the news of a collaboration of a drug in p1?
The technology is unproven, but beyond that, pancreatic cancer notoriously resistant to treatment. The risk of failure is considerable, and likely greater than the risk of success.
It's because it can't stand your whining and crying. Stop watching the pps every second. Go outside and ride your tricycle.
He is reasonably well known in Canada and speaks out about health policy. It's possible that he's short, but I think this is just one of his policy initiatives. He apparently criticized WHO a while ago for advocating what he thought was substandard malaria treatment, and global policy changed (though I don't know if that was a direct result of his pot-stirring).
As for NLNK, the Canadian Press mentions that "The contract between Canada and NewLink gives the Canadian government some options it could employ if it believes NewLink lacks the capacity to develop the vaccine."